Table 14.
Cardiovascular agents by subtype
N (%) | |
---|---|
Beta blockers | 181 (27.2) |
Metoprolol | 68 (10.2) |
Propranolol | 46 (6.9) |
Atenolol | 32 (4.8) |
Carvedilol | 17 (2.6) |
Labetalol | 9 (1.3) |
Nadolol | 5 (0.8) |
Miscellaneousa | <5 (<0.8) |
Sympatholytics | 175 (26.3) |
Clonidine | 132 (19.8) |
Guanfacine | 43 (6.5) |
Calcium channel antagonists | 97 (14.6) |
Amlodipine | 50 (7.5) |
Verapamil | 22 (3.3) |
Diltiazem | 20 (3.0) |
Miscellaneousb | 5 (0.8) |
Cardiac glycosides | 50 (7.5) |
Digoxin | 46 (6.9) |
Digitoxin | <5 (<0.8) |
ACE inhibitors | 46 (6.9) |
Lisinopril | 39 (5.9) |
Miscellaneousc | 7 (1.1) |
Other antihypertensives and vasodilators | 42 (6.3) |
Prazosin | 16 (2.4) |
Tamsulosin | 8 (1.2) |
Hydralazine | 5 (0.8) |
Miscellaneousd | 13 (2.0) |
Diuretics | 26 (3.9) |
Hydrochlorothiazide | 14 (2.1) |
Furosemide | 5 (0.8) |
Miscellaneouse | 7 (1.1) |
Other cardiovascular agents | 18 (2.7) |
Atorvastatin | 11 (1.7) |
Miscellaneousf | 7 (1.1) |
Antidysrhythmics | 16 (2.4) |
Flecainide | 6 (1.0) |
Sotalol | 5 (0.8) |
Miscellaneousg | 5 (0.8) |
Angiotensin receptor blockers | 14 (2.1) |
Losartan | 8 (1.2) |
Miscellaneoush | 6 (1.0) |
Class total | 665 (100) |
aIncludes nebivolol and bisoprolol
bIncludes nifedipine and felodipine
cIncludes enalapril, captopril, and ramipril
dIncludes isobutyl nitrate, alkyl nitrite, antihypertensive unspecified, nitroglycerin, minoxidil, nitroprusside, isosorbide, and terazosin
eIncludes spironolactone, triamterene, acetazolamide, pamabrom, and torsemide
fIncludes simvastatin, fenofibrate, midodrine, and pravastatin
gIncludes amiodarone, propafenone, and quinidine
hIncludes valsartan, olmesartan, and irbesartan